Literature DB >> 8685323

Diffuse lung disease: assessment with helical CT--preliminary observations of the role of maximum and minimum intensity projection images.

M Bhalla1, D P Naidich, G McGuinness, J F Gruden, B S Leitman, D I McCauley.   

Abstract

PURPOSE: To evaluate assessment of diffuse lung disease with helical computed tomography (CT) and maximum intensity projection (MIP) and minimum intensity projection images.
MATERIALS AND METHODS: Six patients with suspected lung disease (the control group) and 20 patients with documented disease underwent axial helical CT through the upper and lower lung fields. Findings on the MIP and minimum intensity projection images of each helical data set were compared with findings on the thin-section scan obtained at the midplane of the series.
RESULTS: Owing to markedly improved visualization of peripheral pulmonary vessels (n = 26) and improved spatial orientation, MIP images were superior to helical scans to help identify pulmonary nodules and characterize them as peribronchovascular (n = 2) or centrilobular (n = 7). Minimum intensity projection images were more accurate than thin-section scans to help identify lumina of central airways (n = 23) and define abnormal low (n = 15) and high (ground-glass) (n = 8) lung attenuation. Conventional thin-section scans depicted fine linear structures more clearly than either MIP or minimum intensity projection images, including the walls of peripheral, dilated airways (n = 3) and interlobular septa (n = 3). MIP and minimum intensity projection images added additional diagnostic findings to those on thin-section scans in 13 (65%) of 20 cases.
CONCLUSION: MIP and minimum intensity projection images of helical data sets may help diagnosis of a wide spectrum of diffuse lung diseases.

Entities:  

Mesh:

Year:  1996        PMID: 8685323     DOI: 10.1148/radiology.200.2.8685323

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

Review 1.  Imaging studies in emphysema.

Authors:  Paul J Friedman
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

2.  Diagnostic potential of virtual bronchoscopy: advantages in comparison with axial CT slices, MPR and mIP?

Authors:  U Rapp-Bernhardt; T Welte; W Doehring; S Kropf; T M Bernhardt
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

Review 3.  CT protocols in interstitial lung diseases--a survey among members of the European Society of Thoracic Imaging and a review of the literature.

Authors:  Helmut Prosch; Cornelia M Schaefer-Prokop; Edith Eisenhuber; Daniela Kienzl; Christian J Herold
Journal:  Eur Radiol       Date:  2012-12-13       Impact factor: 5.315

4.  In-depth morphological study of mesiobuccal root canal systems in maxillary first molars: review.

Authors:  Seok-Woo Chang; Jong-Ki Lee; Yoon Lee; Kee-Yeon Kum
Journal:  Restor Dent Endod       Date:  2013-02-26

5.  Comparison of the rebuilding effects of different computed tomography scanners and reconstructive settings for the five-line sign in normal interlobular fissures.

Authors:  Anle Yu; Qun Li; Yuefu Zhan; Jinlong He
Journal:  Eur Radiol Exp       Date:  2017-10-19

6.  Value of minimum intensity projections for chest CT in COVID-19 patients.

Authors:  Christian Booz; Thomas J Vogl; U Joseph Schoepf; Damiano Caruso; Maria Cristina Inserra; Ibrahim Yel; Simon S Martin; Andreas M Bucher; Lukas Lenga; Danilo Caudo; Teresa Schreckenbach; Niklas Schoell; Christian Huegel; Jan Stratmann; Mariuca Vasa-Nicotera; Daniel E Rachovitsky-Duarte; Andrea Laghi; Domenico De Santis; Silvio Mazziotti; Tommaso D'Angelo; Moritz H Albrecht
Journal:  Eur J Radiol       Date:  2020-12-14       Impact factor: 4.531

7.  Subcentimeter pulmonary nodules detected in patients with sarcoma.

Authors:  M S Ginsberg; D M Panicek
Journal:  Sarcoma       Date:  2000

8.  Minimum-intensity projection images in high-resolution computed tomography lung: Technology update.

Authors:  Nitin P Ghonge; Veena Chowdhury
Journal:  Lung India       Date:  2018 Sep-Oct
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.